Squinto Stephen P Insider Trades

Insider Trading History

Track insider trading activity for Squinto Stephen P. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Director
Holding Value $6.19M 131,652 shares
Last Trade
May 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$171k 4,818 shares
$35.42
$46.99
Compass Therapeutics
Compass Therapeutics CMPX
Director
Holding Value $63k 30,000 shares
Last Trade
Feb 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72k 30,000 shares
$2.40
$2.10
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
10% owner
Holding Value $5.96M 126,834 shares
Last Trade
May 20, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$531k 6,998 shares
$75.94
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
10% owner
Holding Value $5.91M 125,728 shares
Last Trade
Apr 28, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.47M 19,231 shares
$76.20
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
10% owner
Holding Value $6.81M 144,959 shares
Last Trade
Apr 27, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$15.1k 201 shares
$75.05
$46.99
Chemomab Therapeutics
Chemomab Therapeutics CMMB
Director
Holding Value $39.9k 23,768 shares
Last Trade
Apr 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$820k 23,768 shares
$34.49
$1.68
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
10% owner
Holding Value $6.82M 145,160 shares
Last Trade
Apr 15, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$79.3k 1,057 shares
$75.01
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
10% owner
Holding Value $6.87M 146,217 shares
Last Trade
Apr 14, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$38.4k 511 shares
$75.08
$46.99
Chemomab Therapeutics
Chemomab Therapeutics CMMB
Director
Holding Value $80.5k 47,938 shares
Last Trade
Mar 16, 2021 Sale
$22.9M 75,823 shares
$301.44
$1.68
Compass Therapeutics
Compass Therapeutics CMPX
Director
Holding Value $63k 30,000 shares
Last Trade
Aug 06, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$2.10
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
10% owner
Holding Value $351k 7,464 shares
Last Trade
May 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$284k 7,464 shares
$38.03
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
10% owner
Holding Value $940k 20,000 shares
Last Trade
Mar 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$575k 20,000 shares
$28.76
$46.99
Passage Bio
Passage Bio PASG
Head Of Research And Dev
Holding Value $1.11M 185,776 shares
Last Trade
Feb 27, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$5.97
Passage Bio
Passage Bio PASG
Head Of Research And Dev
Holding Value $3.99M 668,575 shares
Last Trade
Feb 27, 2020 Sale
No data
No data
$5.97
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
10% owner
Holding Value $348M 7,406,307 shares
Last Trade
Sep 17, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.48M 275,000 shares
$23.56
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
10% owner
Holding Value $6.89M 146,728 shares
Last Trade
Sep 12, 2019 Sale
No data
No data
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
10% owner
Holding Value $1.41M 29,983 shares
Last Trade
Sep 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$46.99
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Chief Global Ops. Officer
Holding Value $19.8M 108,577 shares
Last Trade
Oct 27, 2014 Sale (Open Market)Shares sold on the open market or in a private sale.
$723k 3,841 shares
$188.36
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Chief Global Ops. Officer
Holding Value $20M 109,343 shares
Last Trade
Oct 27, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$476k 2,475 shares
$192.20
$182.50
Alexion Pharmaceuticals
Alexion Pharmaceuticals ALXN
Evp, Chief Global Ops. Officer
Holding Value $20.5M 112,418 shares
Last Trade
Oct 27, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$591k 3,075 shares
$192.20
$182.50

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up